Clinical Proteomics units,
University of Milano Bicocca (UNIMIB)
Further Information : http://www.unimib.it/go/46541/Home/English/Departments-and-Schools/Health-Science
The Clinical Proteomics unit of the University of Milano Bicocca (UNIMIB) is part of the Depart. of Health Sciences of the UNIMIB. The Department is located in in Monza. Assistance and clinical researchare arranged in the San Gerardo Hospital. The type of research activity is mainly biological-medical, but also epidemiological and clinical. The UNIMIB Proteomics Research Unit has experience on several proteomics strategies based on different approaches. The unit is equipped with different proteomics technologies available for the iMODE-CKD, project including systems for two-dimensional electrophoresis, nano-liquid chromatography systems, matrix assisted laser desorption-ionization time-of-flight mass spectrometers (MALDI-TOF/TOF) with imaging MS capabilities, electrospray- mass spectrometers (ESI-qTOF and ion trap) etc.
Fulvio Magni, Ph.D is group leader of the Clinical Proteomics Unit (UNIMIB). He graduated in Chemistry and Pharmaceutical Technologies (Milan) and he has a PhD in Pharmacology and Toxicology. Part of his training was spent at the University of Illinois at Chicago (Illinois, USA). He was part of Management Committee of the European Kidney and Urine Proteomics (www.eurokup.org; 2008-2012) and is currently involved in the MC of the BM1104 Mass Spectrometry Imaging: New Tools for Healthcare Research (http://www.imaging-ms.org/) COST Actions. He is currently investigating the proteome/peptidome in biological fluids and tissues of Renal Cell Carcinoma and of Diabetic Type 1 patients by LC-ESI-MS/MS and MALDI-TOF/TOF aimed to biomarkers discovery for early diagnosis and prognosis. Actually, he is PI of one unit of the Italian Human Proteome Net and of a network of laboratories dedicated to drug devolpment funded by Regione Lombardia.
Clizia Chinello Ph.D started research activities at Clinical Proteomics Unit (UNIMIB) in 2004 after specialist B.Sc. in Biotechnology from University of Milano. In 2005, she obtained a one-year-Master degree in Bioinformatics and in 2008, she received her PhD, from University of Milano-Bicocca, Med School in Italy. Her 9-year research experience in mass spectrometry field was dedicated on clinical proteomics/peptidomics both in biological fluids and in tissues. Her current research interests are mainly focused on molecular alteration of kidney malignancies and injuries through quantitative MS proteomic strategies.